Emerging peptide therapeutics for inflammatory diseases

Current Pharmaceutical Biotechnology

Volumn 7, Issue 4, 2006, Pages 241-246

  Vally, Maya ^a   Seenu, Sujatha ^b   Pillarisetti, Sivaram ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b Reddy US Therapeutics   (United States)

Author keywords

AI peptide; AVP 26452; Complement C5a Antagonist; Inflammation; NSAIDs; Reverse D 4F

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; AP 214; APP 018; AT 001; AVP 26452; AVR 118; B 9430; B 9870; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C5 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYLGLYCYL DEXTRO TYROSINAMIDE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLCYSTEINYLTHREONINAMIDE 2,6 DISULFIDE; ETANERCEPT; FX 06; ICATIBANT; IMMUNOMODULATING AGENT; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ANTAGONIST; IR 208; JPD 003; NEUROVAX; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE DERIVATIVE; R 1599; R 411; RETICULOSE; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE COURSE; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG USE; ENTERITIS; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATORY DISEASE; INHIBITION KINETICS; LIVER CIRRHOSIS; NEPHROTOXICITY; NONHUMAN; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL PRODUCTS; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; INFLAMMATION; PEPTIDES;

EID: 33746905117     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920106777950816     Document Type: Review

References (35)

1. DeVeale, B.; Brummel, T.; Seroude, L. (2004) Aging Cell, 3(4), 195-208.
2. Licastro, F.; Candore, G.; Lio, D.; Porcellini, E.; Colonna-Romano, G.; Franceschi, C.; Caruso, C. (2005) Immun. Ageing, 18, 2-8.
3. Lemanske, F.; Busse, W. (2006) J. Allergy Clin. Immunol., 117(2 Suppl), S456-61.
4. Griffin, W.S. (2006) Am. J. Clin. Nutr., 83(2), 470S-474S.
5. Means, T. (2004) Hematology, 9(5-6), 357-62.
6. Monraats, P.S.; Pires, N.M.; Schepers, A.; Agema, W.R.; Boesten, L.S.; de Vries, M.R.; Zwinderman, A.H.; de Maat, M.P.; Doevendans, P.A.; de Winter, R.J.; Tio, R.A.; Waltenberger, J.; t Hart, L.M.; Frants, R.R.; Quax, P.H.; van Vlijmen, B.J.; Havekes, L.M.; van der Laarse, A.; van der Wall, E.E.; Jukema, J.W. (2005) FASEB J., 19(14), 1998-2004.
7. Weyand, C.M.; Goronzy, J.J. (2006) J. Clin. Invest., 116(4), 869-71.
8. Lu, H.; Ouyang, W.; Huang, C. (2006) Mol. Cancer Res., 4(4), 221-33.
9. Govindarajan, G.; Whaley-Connell, A.; Mugo, M.; Stump, C.; Sowers, J.R. (2005) Am. J. Med. Sci., 330(6), 311-8.
10. Otero, M.; Lago, R.; Gomez, R.; Lago, F.; Gomez-Reino, J.; Gualillo, O. (2006) Drug News Perspect., 19(1), 21-6.
11. Bennett, R. (2005) Curr. Rheumatol. Rep., 7(5), 371-6.
12. Libby, P. (2002) Nature, 420(6917), 868-74.
13. Kelly, J. (2006) Semin. Nephrol., 26(2), 105-13.
14. Takeuchi, T.; Tsuzaka, K.; Kameda, H.; Amano, K. (2005) Curr. Drug Targets Inflamm. Allergy, 4(3), 295-8.
15. Bos, D.; de Rie, A.; Teunissen, B.; Piskin, G. (2005) Br. J. Dermatol., 152(6), 1098-107.
16. McMurray, R.W.; Hardy, K.J. (2002) Am. J. Med. Sci., 323, 181-9.
17. Cook D, Visvanathan K (2004) Expert Opin. Ther. Targets, 8(5), 375-90.
18. Groner, B.; Hartmann, C.; Wels, W. (2004) Curr. Mol. Med., 4(5), 539-47.
19. Borghouts, C.; Kunz, C.; Groner, B. (2005) J. Pept. Sci., 11(11), 713-26.
20. Borghouts, C.; Kunz, C.; Groner, B. (2005) Expert Opin. Biol. Ther., 5(6), 783-97.
21. Joliot, A.; Prochiantz, A. (2004) Nat. Cell Biol., 6(3), 189-96.
22. Navab, M.; Anantharamaiah, M.; Hama, S.; Garber, W.; Chaddha, M.; Hough, G.; Lallone, R.; Fogelman, M. (2002) Circulation, 105(3), 290-2.
23. Prakken, J.; Samodal, R.; Le, D.; Giannoni, F.; Yung, P.; Scavulli, J.; Amox, D.; Roord, S.; de Kleer, I.; Bonnin, D.; Lanza, P.; Berry, C.; Massa, M.; Billetta, R.; Albani, S. (2004) Proc. Nat.l Acad. Sci. USA, 101(12), 4228-33.
24. Allegretti, M.; Moriconi, A.; Beccari, R.; Di Bitondo, R.; Bizzarri, C.; Bertini, R.; Colotta, F. (2005) Curr. Med. Chem., 12, 217-36.
25. Darlington, L. (2005) Curr. Opin. Mol. Ther., 7(6), 598-603.
26. Moss, B.; Moll, T.; El-Kalay, M.; Kohne, C.; Soo, Hoo, W.; Encinas, J.; Carlo, J. (2004) Expert Opin. Biol. Ther., 4(12), 1887-96.
27. Wang, W. (2003) Curr. Opin. Mol. Ther., 5(2), 186-91.
28. Hijazi, Y.; Welker, H.; Dorr, A.E.; Frank, K.; Renzetti, L.M.; Patel, I. (2006) Eur. J. Clin. Pharmacol., 62(1), 83-5.
29. Iyer, S.; Lahana, R.; Buelow, R. (2002) Curr. Pharm. Des., 8(24), 2217-29.
30. DeVry, G.; Valdez, M.; Gao, L.; Wang, J.; Kotsch, K.; Volk, D.; Bechmann, I.; Buelow, R.; Iyer, (2004) J. Neuroimmunol., 152, 33-43.
31. Cuturi, C.; Christoph, F.; Woo, J.; Iyer, S.; Brouard, S.; Heslan, J.M.; Pignon, P.; Soulillou, P.; Buelow, R. (1999) Mol. Med., 5(12), 820-32.
32. Zhao, J.; Huang, L.; Belmar, N.; Buelow, R and Fong, T. (2004) Gastrointest. Toxic. Clin. Cancer Res., 10, 2851-2859.
33. Travis, S.; Yap, L.M.; Hawkey, C.; Warren, B.; Lazarov, M.; Fong, T.; Tesi RJ; RDP Investigators Study Group. (2005) Inflamm. Bowel. Dis., 11(8), 713-9.
34. Life Sci. News Briefs, (2005), 5(29).
35. www.Iddb.com